Post job

Par Pharmaceutical Inc's revenue is $260.0 million.

What is Par Pharmaceutical Inc's revenue?

Par Pharmaceutical Inc's annual revenue is $260.0M. Zippia's data science team found the following key financial metrics about Par Pharmaceutical Inc after extensive research and analysis.
  • Par Pharmaceutical Inc has 400 employees, and the revenue per employee ratio is $650,000.
  • Par Pharmaceutical Inc peak revenue was $260.0M in 2024.

On this page

Peak revenue
$260.0M (2025)
Company peak revenue
Revenue / employee
$650,000
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$260.0M (2025)
Company peak revenue
Revenue / employee
$650,000
Company revenue / employee

Par Pharmaceutical Inc competitors

Par Pharmaceutical Inc revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Par Pharmaceutical Inc, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Par Pharmaceutical Inc. The employee data is based on information from people who have self-reported their past or current employments at Par Pharmaceutical Inc. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Par Pharmaceutical Inc. The data presented on this page does not represent the view of Par Pharmaceutical Inc and its employees or that of Zippia.

Par Pharmaceutical Inc may also be known as or be related to Par Pharmaceutical Inc and Par Pharmaceutical Inc.